KLRS - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Kalaris Therapeutics, Inc.

Kalaris Therapeutics, Inc. (KLRS) - logo korporat

Kalaris Therapeutics Inc (KLRS) relies on patent-protected molecules to ensure a stable cash flow. The development of retinal therapies is supported by unique drug delivery methods. Strong physician interest in clinical trials confirms the brand's scientific authority. Quarterly earnings per share (EPS) growth illustrates financial stability, where the value 26.70 represents the current figure for this metric.

Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Kalaris Therapeutics (KLRS): kanggo periode 20.03.2025 - 18.11.2026

KLRS (kalaristx.com): rincian analitis lan laporan miturut indikator

- statistik kapitalisasi pasar:
Barang unggulan Kalaris Therapeutics Inc

Developing viral therapies in collaboration with medical centers requires significant expenditures, so the quarterly earnings per share trend for Kalaris Therapeutics Inc (KLRS) allows for an assessment of capital management efficiency and the impact of fiscal factors on net value. The current value of 26.70 reflects profit growth rates, helping investors correlate the risks of frozen funds with the asset's potential yield during the intervals between financial reports.

Analisis pesaing

Gilead Sciences Inc (GILD) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Cidara - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan NVAX|Wutah bathi EPS kuartalan curevac.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Valneva Corp (VALN)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan VIR (Vir Biotechnology)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan TPOXX SIGA|EBS - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|AVIR: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|IVVD (Invivyd Inc) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|ENTA: Wutah bathi EPS kuartalan|INO (Inovio) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan HilleVax Corp|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan DYAI (Dyadic International)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan NNVC (NanoViricides)|TLPH (Talphera, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Cocrystal Pharma Inc COCP|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan TRAW|Dogwood Therapeutics Inc. - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Qualigen Corp|ALVR (AlloVir Bio) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan VBI Vaccines, Inc.|VIRI (virios.com) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan VXRT (Vaxart, Inc.)